MX2015006011A - Pastilla medicinal a base de ibuprofeno sodico dihidratado. - Google Patents

Pastilla medicinal a base de ibuprofeno sodico dihidratado.

Info

Publication number
MX2015006011A
MX2015006011A MX2015006011A MX2015006011A MX2015006011A MX 2015006011 A MX2015006011 A MX 2015006011A MX 2015006011 A MX2015006011 A MX 2015006011A MX 2015006011 A MX2015006011 A MX 2015006011A MX 2015006011 A MX2015006011 A MX 2015006011A
Authority
MX
Mexico
Prior art keywords
sodium dihydrate
ibuprofen sodium
medicinal
lozenge based
medicinal lozenge
Prior art date
Application number
MX2015006011A
Other languages
English (en)
Inventor
Jean-Francois Cordoliani
Nadine Harambillet
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48050846&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2015006011(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of MX2015006011A publication Critical patent/MX2015006011A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

El tema de la presente invención son las pastillas medicinales para chupar, que tienen una consistencia sólida de tal manera que se disuelven en la cavidad oral, que comprenden al menos ibuprofeno sódico dihidratado como ingrediente activo, las cuales se destinan al tratamiento de condiciones orofaríngeas.
MX2015006011A 2012-11-14 2013-11-14 Pastilla medicinal a base de ibuprofeno sodico dihidratado. MX2015006011A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1260815A FR2997856B1 (fr) 2012-11-14 2012-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
PCT/EP2013/073868 WO2014076203A1 (fr) 2012-11-14 2013-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate

Publications (1)

Publication Number Publication Date
MX2015006011A true MX2015006011A (es) 2015-09-10

Family

ID=48050846

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015006011A MX2015006011A (es) 2012-11-14 2013-11-14 Pastilla medicinal a base de ibuprofeno sodico dihidratado.

Country Status (17)

Country Link
US (1) US20160287514A1 (es)
EP (1) EP2919752A1 (es)
JP (1) JP6258342B2 (es)
KR (1) KR20150084919A (es)
CN (1) CN104780907A (es)
AP (1) AP2015008515A0 (es)
AU (1) AU2013346775B2 (es)
BR (1) BR112015010808A2 (es)
CA (1) CA2890832A1 (es)
CL (1) CL2015001308A1 (es)
FR (1) FR2997856B1 (es)
MA (1) MA38162B1 (es)
MX (1) MX2015006011A (es)
RU (1) RU2015122217A (es)
TN (1) TN2015000176A1 (es)
WO (1) WO2014076203A1 (es)
ZA (1) ZA201504280B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7214331B2 (ja) * 2016-12-28 2023-01-30 小林製薬株式会社 医薬組成物
WO2019104050A1 (en) * 2017-11-27 2019-05-31 Lodaat Pharmaceuticals Methods for preparing curcuminoid compositions
US20220313710A1 (en) * 2019-08-22 2022-10-06 Applied Biological Laboratories, Inc. Compositions and methods using non-steroidal anti-inflammatory drugs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2148175T3 (es) * 1991-05-13 2000-10-16 Boots Co Plc Composicion farmaceutica que contiene una sal de ibuprofeno.
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
US20060286164A1 (en) * 2004-06-07 2006-12-21 Iyer Venkat S Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
CA2576642A1 (en) * 2004-08-12 2006-02-16 Reckitt Benckiser Healthcare (Uk) Limited Granules comprising a nsaid and a sugar alcohol made by melt extrusion
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
BRPI0618273A2 (pt) * 2005-11-02 2011-08-23 Teikoku Pharma Usa Inc formulações de dosagem oral de ibuprofeno organolepticamente aceitáveis, métodos de produção e uso das mesmas
JP2009538359A (ja) * 2006-05-26 2009-11-05 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換カルボン酸化合物の製造および利用
CN102557918B (zh) * 2011-11-28 2013-08-21 海南永田药物研究院有限公司 一种布洛芬钠化合物及其制法

Also Published As

Publication number Publication date
MA38162B1 (fr) 2019-12-31
WO2014076203A1 (fr) 2014-05-22
BR112015010808A2 (pt) 2017-07-11
CA2890832A1 (fr) 2014-05-22
AP2015008515A0 (en) 2015-06-30
CN104780907A (zh) 2015-07-15
TN2015000176A1 (fr) 2016-10-03
RU2015122217A (ru) 2017-01-10
JP6258342B2 (ja) 2018-01-10
CL2015001308A1 (es) 2015-08-28
EP2919752A1 (fr) 2015-09-23
FR2997856B1 (fr) 2015-04-24
ZA201504280B (en) 2017-09-27
JP2015537019A (ja) 2015-12-24
MA38162A1 (fr) 2016-12-30
FR2997856A1 (fr) 2014-05-16
KR20150084919A (ko) 2015-07-22
US20160287514A1 (en) 2016-10-06
AU2013346775B2 (en) 2018-06-28
AU2013346775A1 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
MX2021000550A (es) Forma de dosis orales de liberacion sostenida de tofacitinib.
MX2019003249A (es) Diagnostico, prevencion y tratamiento de enfermedades de la articulacion.
GEP20186903B (en) Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration
BR112012016853A2 (pt) "composições farmacêuticas para administração oral de peptídeos de insulina".
MY183312A (en) Pharmaceutical formulation
CY1118032T1 (el) Διεργασιες για την εμπορικη παρασκευη φαρμακευτικα δραστικου παραγοντα
MX356728B (es) Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2.
PL3003285T3 (pl) Stała farmaceutyczna postać dawkowania do uwalniania co najmniej dwóch substancji czynnych w jamie ustnej
PH12015500823A1 (en) Modified release formulations for oprozomib
MX340983B (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
MX343689B (es) Formulaciones combinadas de darunavir.
PH12015501783B1 (en) Pharmaceutical compositions for the treatment of helicobacter pylori
MX341976B (es) Formulaciones de darunavir.
MX2012001691A (es) Composiciones de linaclotida que se desintegran oralmente.
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
MX2015006011A (es) Pastilla medicinal a base de ibuprofeno sodico dihidratado.
MX2016006087A (es) Formulaciones de desintegracion rapida y metodos de uso.
WO2012074830A3 (en) Modified release tranexamic acid formulation
MX2015010486A (es) Composicion masticable para administracion oral y proceso para preparar la misma.
NZ715615A (en) Pharmaceutical compositions of ranolazine and dronedarone
EA201491477A1 (ru) Фармацевтические составы, содержащие флупиртин
UA110792C2 (uk) Лікарська форма бендамустину для перорального застосування
MX2015013279A (es) Forma de dosis orales de liberacion sostenida de tofacitinib.
MX2012014498A (es) Composicion farmaceutica de rosuvastatina.
TR201203087A2 (tr) Seftibüten ve klavulanik asit formülasyonları.